2-aminopurine has been researched along with Disease Models, Animal in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 11 (55.00) | 29.6817 |
2010's | 3 (15.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Adriaenssens, E; Amand, S; Bailly, C; Benhabiles, H; Chassat, T; Copin, MC; Duvernois-Berthet, E; Guilbert, R; Hannebique, D; Kulozik, A; Lejeune, F; Leroy, C; Marchand, V; Moreau, PA; Motorin, Y; Mouray, A; Rebuffat, S; Saliou, JM; Trzaska, C; Tulasne, D; Werkmeister, E; Westhof, E | 1 |
Chen, Y; Pan, Y; Qin, Y; Xiang, R; Yang, J; Yang, SY; Zheng, M; Zhong, L; Zhou, S | 1 |
Fukuda, M; Higaki, S; Komoto, S; Shimomura, Y | 1 |
Haneji, T; Nagata, T; Okamura, H; Shinohara, H; Teramachi, J; Yang, D | 1 |
Edden, Y; Hartshtark, Z; Ilan, L; Khalaileh, A; Kolodkin-Gal, D; Panet, A; Pikarsky, AJ; Pikarsky, E; Rabkin, SD; Zamir, G | 1 |
Jarisch, J; Smith, AL; Watson, ME | 1 |
Oyston, PCF; Taylor, VL; Titball, RW | 1 |
Biswas, S; Field, HJ; Jennens, L | 1 |
Maung, M; Slomka, MJ; Tsiquaye, KN | 1 |
Field, HJ; Thackray, AM | 2 |
Färber, I; Ulbricht, A; Wutzler, P | 1 |
Main, J; McCarron, B; Thomas, HC | 1 |
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC | 1 |
Benfield, DA; Guanghua, L; Kim, TS; Lawson, SR; Robinson, B; Rowland, RR; Stefanick, J | 1 |
Higaki, S; Hill, JM; Kesavan, P; Loutsch, JM; Marquart, ME; Sainz, B; Tal-Singer, R; Zheng, X | 1 |
Chen, Y; Guo, S; Huang, A; Qi, Z | 1 |
Bang, D; Kwon, HJ; Lee, ES; Lee, S; Lee, SI; Sohn, S | 1 |
Field, HJ; Gürr, WK; Littler, E; Shaw, MM; Thackray, AM; Watts, PA | 1 |
1 review(s) available for 2-aminopurine and Disease Models, Animal
Article | Year |
---|---|
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1998 |
19 other study(ies) available for 2-aminopurine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations.
Topics: 2-Aminopurine; Animals; Codon, Nonsense; Disease Models, Animal; Drug Discovery; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genes, p53; HEK293 Cells; HeLa Cells; Humans; Lepisma; Mice; Mice, Nude; Mutation; RNA, Transfer; tRNA Methyltransferases | 2020 |
A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Topics: 2-Aminopurine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; ErbB Receptors; Female; G1 Phase; Humans; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Piperazines; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Recombinant Proteins; Resting Phase, Cell Cycle; Signal Transduction; src-Family Kinases; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2015 |
Effects of antiviral medications on herpetic epithelial keratitis in mice.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Disease Models, Animal; DNA Copy Number Variations; DNA, Viral; Epithelium, Corneal; Eye Infections, Viral; Famciclovir; Female; Herpesvirus 1, Human; Keratitis, Herpetic; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Tears; Trigeminal Nerve; Valacyclovir; Valine | 2015 |
Double Stranded RNA-Dependent Protein Kinase is Necessary for TNF-α-Induced Osteoclast Formation In Vitro and In Vivo.
Topics: 2-Aminopurine; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Disease Models, Animal; eIF-2 Kinase; Gene Expression Regulation; In Vitro Techniques; Macrophages; Mice; Osteoclasts; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.
Topics: 2-Aminopurine; Adenocarcinoma; Animals; Antimetabolites; Apoptosis; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Colonic Neoplasms; Disease Models, Animal; Drug Therapy, Combination; eIF-2 Kinase; Gene Transfer Techniques; Genes, Reporter; Genetic Vectors; Herpesvirus 1, Human; Humans; Injections, Intralesional; Luciferases; Male; Mice; Neoadjuvant Therapy; Oncolytic Virotherapy; Oncolytic Viruses; Phosphorylation; Rectal Neoplasms; Viral Tropism; Virus Replication | 2009 |
Inactivation of deoxyadenosine methyltransferase (dam) attenuates Haemophilus influenzae virulence.
Topics: 2-Aminopurine; Adenosine Triphosphatases; Animals; Bacterial Proteins; Cell Line; Cytoplasm; Deoxyribonucleases, Type II Site-Specific; Disease Models, Animal; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; Endothelial Cells; Epithelial Cells; Gene Deletion; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genetic Complementation Test; Haemophilus Infections; Haemophilus influenzae; Humans; Mutagenesis, Insertional; MutS DNA Mismatch-Binding Protein; Rats; Site-Specific DNA-Methyltransferase (Adenine-Specific); Virulence | 2004 |
Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague.
Topics: 2-Aminopurine; Animals; Anti-Bacterial Agents; Bacterial Vaccines; Bile Acids and Salts; Deoxyribonucleases, Type II Site-Specific; Disease Models, Animal; DNA, Bacterial; Female; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Plague; Site-Specific DNA-Methyltransferase (Adenine-Specific); Survival Analysis; Vaccines, Attenuated; Virulence; Yersinia pestis; Yersinia pseudotuberculosis | 2005 |
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Topics: 2-Aminopurine; Administration, Oral; Animals; Antiviral Agents; Brain Stem; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ear; Famciclovir; Herpes Simplex; Herpesvirus 1, Human; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, Nude; Pyridines; Skin; Sulfonamides; Thiazoles | 2007 |
Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Animals; Animals, Newborn; Antiviral Agents; Biotransformation; Disease Models, Animal; DNA, Viral; Ducks; Eggs; Famciclovir; Guanine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Kidney; Liver; Organ Specificity; Pancreas; Poultry Diseases; Prodrugs; Spleen; Viremia; Virus Replication; Xanthine Oxidase | 1994 |
Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Animals; Antiviral Agents; Brain Stem; Disease Models, Animal; Ear, External; Famciclovir; Female; Ganglia, Spinal; Herpes Simplex; Herpesvirus 1, Human; Mice; Mice, Inbred BALB C; Prodrugs; Trigeminal Ganglion; Valacyclovir; Valine; Virus Activation; Virus Latency; Virus Replication | 1996 |
Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Disease Models, Animal; Famciclovir; Hepatitis, Animal; Herpes Zoster; Herpesvirus 1, Human; Liver; Mice; Mice, Inbred BALB C; Valacyclovir; Valine; Viral Plaque Assay; Virus Replication | 1997 |
Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Disease Models, Animal; Famciclovir; Herpes Simplex; Herpesvirus 1, Human; Mice; Recurrence; Valacyclovir; Valine; Virus Latency | 2000 |
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combination; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Marmota; Prodrugs; Reverse Transcriptase Inhibitors; Viremia; Virus Replication | 2000 |
Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine.
Topics: 2-Aminopurine; Animals; Animals, Newborn; Antiviral Agents; Blotting, Northern; Cell Line; Cell Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; eIF-2 Kinase; Fluorescence; Interferon-gamma; Lung; Lymph Nodes; Porcine Reproductive and Respiratory Syndrome; Porcine respiratory and reproductive syndrome virus; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Swine Diseases; Virus Replication | 2001 |
Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Topics: 2-Aminopurine; Acute Disease; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Corneal Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Famciclovir; Herpes Simplex; Herpesvirus 1, Human; Keratitis, Herpetic; Rabbits; Trifluridine; Trigeminal Ganglion; Viral Load; Virus Latency | 2001 |
[Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Topics: 2-Aminopurine; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Ducks; Famciclovir; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Microbial Sensitivity Tests | 2001 |
Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Behcet Syndrome; Disease Models, Animal; Famciclovir; Herpes Simplex; Interleukin-2; Mice; Mice, Inbred ICR; Prodrugs; Recurrence; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analogues.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Apoptosis; Brain Stem; Disease Models, Animal; DNA Fragmentation; Famciclovir; Female; Ganciclovir; Guanine; Herpes Simplex; Herpesvirus 1, Human; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Valacyclovir; Valine | 2002 |